News

Genomic analysis provides insight into underpinnings of new treatment combination for deadly, Asian-prevalent lymphoma
A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings ...
American Idol winner, Blue Springs native David Cook to host benefit concert for officer battling cancer
American Idol winner and Blue Springs native David Cook will be back in town this weekend to support a police officer who’s ...
Wells says Summit, Akeso data ‘not the bull case,’ but not ‘bear case either’
Wells Fargo notes that Summit Therapeutics (SMMT) partner Akeso (AKESF) received approval from China’s NMPA for ivonescimab as a monotherapy ...
Vietnam Investment Review on MSN2d
Ivonescimab Approved in China as First-Line Treatment for PD-L1+ Lung Cancer
Ivonescimab is the first therapy to achieve statistically significant positive results in a Phase III trial compared with ...
MedPage Today27d
Managing Newly Diagnosed Follicular Lymphoma
Follicular lymphoma -- typically a slow-growing or indolent form of non-Hodgkin lymphoma that arises from B lymphocytes -- accounts for 20% to 30% of all non-Hodgkin lymphoma cases. The indolent ...